Bowles L Thompson 4
4 · REGENERX BIOPHARMACEUTICALS INC · Filed Oct 14, 2009
Insider Transaction Report
Form 4
Bowles L Thompson
Director
Transactions
- Award
Stock Options (right to buy)
2009-10-12+15,000→ 15,000 totalExercise: $0.76Exp: 2016-10-12→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]Options granted under the RegeneRx Biopharmaceuticals, Inc. Amended and Restated 2000 Stock Option and Incentive Plan vest over four years in four equal annual installments beginning with the first anniversary of the date of grant.